Amgen

Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it
CNBC
Thu, 05/18/23 - 08:42 pm
Horizon Therapeutics
M&A
Amgen
FTC
Supreme Court rules against Amgen bid to revive cholesterol drug patents
KFGO/Reuters
Thu, 05/18/23 - 11:24 am
Supreme Court
Amgen
Sanofi
Regeneron
patents
Repatha
legal
Few signs of gout pipeline flaring up
EP Vantage
Thu, 05/18/23 - 10:45 am
gout
Selecta Biosciences
Sobi
SEL-212
3SBio
Amgen
Arthrosi Therapeutics
Atom Bioscience
Dyve Biosciences
Hinova Pharmaceuticals
Horizon Therapeutics
InventisBio
Jiangsu Hengrui Pharmaceuticals
JW Group
LG Chem
Olatec Therapeutics
Shanton Bioscience
Regeneron CEO backs FTC’s attempt to block $28B Amgen-Horizon deal
Medical Marketing and Media
Wed, 05/17/23 - 10:48 pm
Amgen
Horizon Therapeutics
FTC
Regeneron
antitrust
M&A
Leonard Schleifer
Does FTC attempt to block Amgen's Horizon buy spell trouble for Pfizer-Seagen? Not necessarily, analysts say
Fierce Pharma
Wed, 05/17/23 - 11:29 am
FTC
M&A
Amgen
Horizon Therapeutics
Pfizer
Seagen
antitrust
Heightened US antitrust fears rattle biopharma
EP Vantage
Wed, 05/17/23 - 10:12 am
M&A
antitrust
Amgen
Astellas
Bellus Health
Globus Medical
GSK
Horizon Therapeutics
Merck
NuVasive
Pfizer
Prometheus Biosciences
Seagen
Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge
BioSpace
Tue, 05/16/23 - 11:02 pm
Amgen
Horizon Therapeutics
M&A
FTC
FTC sues to block Amgen’s $27.8B deal for Horizon Therapeutics
Medical Marketing and Media
Tue, 05/16/23 - 12:17 pm
Amgen
Horizon Therapeutics
FTC
M&A
Mirati's KRAS drug beats estimates in Q1, but Keytruda combo plan remains unclear
Fierce Pharma
Thu, 05/11/23 - 09:07 pm
Mirati Therapeutics
Krazati
Amgen
Lumakras
lung cancer
Pharma’s Biggest Losses: Once-Dropped Drugs Make Lucrative Comebacks
BioSpace
Wed, 05/10/23 - 10:18 am
Gilead Sciences
GSK
momelotinib
Roche
Eli Lilly
lebrikizumab
Merck
Zejula
Amgen
Galenica
Veltassa
Cubicin
A blockbuster year could be building
EP Vantage
Wed, 05/10/23 - 09:55 am
AbbVie
Amgen
AstraZeneca
Bristol Myers Squibb
Daiichi Sankyo
Eli Lilly
Gilead Sciences
Horizon Therapeutics
Merck
Moderna Therapeutics
Novartis
Novo Nordisk
Pfizer
Regeneron
Roche
Sanofi
Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs
Medical Marketing and Media
Tue, 05/9/23 - 11:24 pm
Amgen
TScan
TargetScan
Crohn's Disease
Amgen, Entera ax $270M oral biologic pact 'out of mutual convenience'
Fierce Biotech
Mon, 05/8/23 - 10:17 am
Amgen
Entera Bio
Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents
Yahoo/Benzinga
Wed, 05/3/23 - 10:41 pm
Amgen
Sandoz
legal
Prolia
Xgeva
patents
denosumab
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
Fierce Pharma
Wed, 05/3/23 - 10:29 pm
Amgen
earnings
Horizon Therapeutics
Chronic hives: Four major clinical trials to watch in 2023
Clinical Trials Arena
Wed, 05/3/23 - 11:53 am
chronic hives
chronic urticaria
clinical trials
Sanofi
Regeneron
dupilumab
Amgen
tezepelumab
Allakos
lirentelimab
Celldex Therapeutics
barzolvolimab
Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too
Fierce Biotech
Fri, 04/28/23 - 10:46 am
Amgen
earnings
Eli Lilly
lupus
Q1 revenues slide for Amgen, Gilead
Medical Marketing and Media
Thu, 04/27/23 - 10:54 pm
Amgen
Gilead Sciences
earnings
Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access
Fierce Pharma
Wed, 04/26/23 - 05:50 pm
AbbVie
Amgen
Bristol Myers Squibb
Eli Lilly
Gilead Sceinces
JNJ
Merck
Pfizer
Regeneron
patents
activists
Amgen faces patent infringement claims on big-selling osteoporosis drug Evenity
Fierce Pharma
Tue, 04/25/23 - 10:10 pm
Amgen
legal
patents
osteoporosis
Evenity
OssiFi-Mab

Pages